What Is Tesamorelin Ipamorelin CJC-1295 No DAC Blend For?
Tesamorelin + Ipamorelin + CJC-1295 3mg (No DAC) represents a triple-peptide research formulation in a lyophilized vial. Laboratories use this cjc 1295 ipamorelin tesamorelin blend format to study growth hormone secretagogue pathways.
What Does Each Component Contribute to Research?
Researchers select this blend because each peptide interacts with the GH axis differently:
What do researchers study Tesamorelin for? In lab models, researchers examine Tesamorelin as a GHRH analogue to study pituitary stimulation and downstream signaling.
What do researchers study Ipamorelin for? Laboratories investigate Ipamorelin for its selective action on the ghrelin/growth hormone secretagogue receptor (GHS-R). Its selectivity in experimental models drives this research interest.
What is the difference between CJC-1295 No DAC vs. With DAC? CJC-1295 No DAC refers to Modified GRF 1-29 without the Drug Affinity Complex (DAC). Labs use the No DAC version when they need a shorter-acting GHRH analogue for pulsatile-release study designs, while the DAC version extends half-life through albumin binding.
How Do Researchers Ensure Purity and Stability?
Researchers verify identity and purity using HPLC and mass spectrometry before experimental use. Manufacturers typically document each lot with a Certificate of Analysis (COA).
Labs use lyophilization to prevent hydrolysis and preserve peptide activity. This method maintains structural integrity and prevents degradation during storage at -20°C.
What Are Common Research Applications?
Researchers use this CJC 1295 ipamorelin tesamorelin blend strictly for in vitro and analytical research, including receptor binding assays, stability testing, and GH-axis pathway mapping. Researchers do not evaluate this blend for human physiological effects outside controlled lab settings.
FOR RESEARCH USE ONLY. NOT FOR HUMAN OR VETERINARY USE, NOT FOR CONSUMPTION OR SELF-ADMINISTRATION. NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE.